- Home
- DIT vs ANEB Comparison
DIT vs ANEB Comparison
Compare DIT & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DIT
- ANEB
- Stock Information
- Founded
- DIT 1981
- ANEB 2020
- Country
- DIT United States
- ANEB United States
- Employees
- DIT N/A
- ANEB N/A
- Industry
- DIT Food Distributors
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- DIT Consumer Discretionary
- ANEB Health Care
- Exchange
- DIT Nasdaq
- ANEB Nasdaq
- Market Cap
- DIT 78.7M
- ANEB 79.9M
- IPO Year
- DIT 1995
- ANEB 2021
- Fundamental
- Price
- DIT $131.78
- ANEB $1.68
- Analyst Decision
- DIT
- ANEB Buy
- Analyst Count
- DIT 0
- ANEB 1
- Target Price
- DIT N/A
- ANEB $8.00
- AVG Volume (30 Days)
- DIT 133.0
- ANEB 5.3K
- Earning Date
- DIT 11-08-2024
- ANEB 11-13-2024
- Dividend Yield
- DIT 0.55%
- ANEB N/A
- EPS Growth
- DIT N/A
- ANEB N/A
- EPS
- DIT 7.15
- ANEB N/A
- Revenue
- DIT $2,141,481,108.00
- ANEB N/A
- Revenue This Year
- DIT N/A
- ANEB N/A
- Revenue Next Year
- DIT N/A
- ANEB N/A
- P/E Ratio
- DIT $18.43
- ANEB N/A
- Revenue Growth
- DIT 8.41
- ANEB N/A
- 52 Week Low
- DIT $118.25
- ANEB $1.46
- 52 Week High
- DIT $209.50
- ANEB $3.30
- Technical
- Relative Strength Index (RSI)
- DIT 49.69
- ANEB 38.91
- Support Level
- DIT $121.00
- ANEB $1.46
- Resistance Level
- DIT $134.89
- ANEB $1.70
- Average True Range (ATR)
- DIT 3.50
- ANEB 0.10
- MACD
- DIT 0.42
- ANEB -0.02
- Stochastic Oscillator
- DIT 71.66
- ANEB 16.67
About DIT AMCON Distributing Company
Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores, and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.